This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Transcriptional repressor DREAM regulates trigeminal noxious perception

Title Transcriptional repressor DREAM regulates trigeminal noxious perception
Abstract

Expression of the downstream regulatory element antagonist modulator (DREAM) protein in dorsal root ganglia and spinal cord is related to endogenous control mechanisms of acute and chronic pain. In primary sensory trigeminal neurons, high levels of endogenous DREAM protein are preferentially localized in the nucleus, suggesting a major transcriptional role. Here, we show that transgenic mice expressing a dominant active mutant of DREAM in trigeminal neurons show increased responses following orofacial sensory stimulation, which correlates with a decreased expression of prodynorphin and brain‐derived neurotrophic factor in trigeminal ganglia. Genome‐wide analysis of trigeminal neurons in daDREAM transgenic mice identified cathepsin L and the monoglyceride lipase as two new DREAM transcriptional targets related to pain. Our results suggest a role for DREAM in the regulation of trigeminal nociception. This article is part of the special article series “Pain” . image

Apa Reference Benedet, T., Gonzalez, P., Oliveros, J.C., Dopazo, J.M., Ghimire, K., Palczewska, M., Mellstrom, B. & Naranjo, J.R. (2017). Transcriptional repressor DREAM regulates trigeminal noxious perception. Journal of Neurochemistry, 141(4), 544-552. 10.1111/jnc.13584
Doi 10.1111/jnc.13584
Publication Date 21 Feb 2017
Publication Type Article
Researcher Juan Carlos Oliveros Collazos
Ontology Regulatory biology, Mutation Analysis and design
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home